Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
American Heart Journal
|
April 24, 2012
The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction
Danielle Duffy, Dajuanicia N Holmes, Matthew T Roe, et al.
Pharmacotherapy
|
June 6, 2014
Novel treatments for familial hypercholesterolemia: pharmacogenetics at work
Jeffrey A Marbach, Jessica L McKeon, Joyce L Ross, et al.
American Heart Journal
|
November 9, 2016
Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke
Michael Valentino, Jad Al Danaf, Andrew Panakos, et al.
Journal of the American Heart Association
|
May 3, 2024
CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction
Bronwyn A Kingwell, Danielle Duffy, Regina Clementi, et al.
Pharmacotherapy
|
April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia
Sony Tuteja, Danielle Duffy, Richard L Dunbar, et al.
Journal of Clinical Pharmacology
|
November 20, 2018
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity
Andreas Gille, Danielle Duffy, Michael A Tortorici, et al.
Mutation Research
|
December 19, 2006
Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profiles
Cathy Hilliard, Rosina Hill, Michael Armstrong, et al.
British Journal of Clinical Pharmacology
|
November 20, 2020
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients
Bo Zheng, Danielle Duffy, Pierluigi Tricoci, et al.
Journal of the American Heart Association
|
April 12, 2022
Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
Bronwyn A Kingwell, Stephen J Nicholls, Elena Velkoska, et al.
Practical Radiation Oncology
|
May 10, 2015
Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold
Harriet B Eldredge-Hindy, Danielle Duffy, Kosj Yamoah, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
American Heart Journal
|
April 24, 2012
The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction
Danielle Duffy, Dajuanicia N Holmes, Matthew T Roe, et al.
Pharmacotherapy
|
June 6, 2014
Novel treatments for familial hypercholesterolemia: pharmacogenetics at work
Jeffrey A Marbach, Jessica L McKeon, Joyce L Ross, et al.
American Heart Journal
|
November 9, 2016
Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke
Michael Valentino, Jad Al Danaf, Andrew Panakos, et al.
Journal of the American Heart Association
|
May 3, 2024
CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction
Bronwyn A Kingwell, Danielle Duffy, Regina Clementi, et al.
Pharmacotherapy
|
April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia
Sony Tuteja, Danielle Duffy, Richard L Dunbar, et al.
Journal of Clinical Pharmacology
|
November 20, 2018
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity
Andreas Gille, Danielle Duffy, Michael A Tortorici, et al.
Mutation Research
|
December 19, 2006
Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profiles
Cathy Hilliard, Rosina Hill, Michael Armstrong, et al.
British Journal of Clinical Pharmacology
|
November 20, 2020
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients
Bo Zheng, Danielle Duffy, Pierluigi Tricoci, et al.
Journal of the American Heart Association
|
April 12, 2022
Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
Bronwyn A Kingwell, Stephen J Nicholls, Elena Velkoska, et al.
Practical Radiation Oncology
|
May 10, 2015
Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold
Harriet B Eldredge-Hindy, Danielle Duffy, Kosj Yamoah, et al.
Page
of 5